← All trials
NCT06334016
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 27, 2025
- Primary completion
- Mar 1, 2028
- Completion date
- Mar 1, 2028
- First posted
- Mar 27, 2024
- Last posted
- Mar 27, 2024
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- State University of New York, BuffaloLead sponsor
- National Institute on Drug Abuse (NIDA)Collaborator
- State University of New York, BuffaloOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.